POS0111 BENEFICIAL EFFECT OF TEMPORARY METHOTREXATE WITHDRAWAL ON B AND T CELL RESPONSES UPON SARS-CoV-2 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS - Castañeda, S.; Vicente-Rabaneda, E.; Martínez-Fleta, P.; Triguero-Martinez, A.; Uriarte-Ecenarro, M.; Gutiérrez-Rodríguez, F.; Quiroga Colina, P.; Romero, A.; García Castañeda, N.; García-Vadillo, J. A.; Valero, C.; Llorente, I.; et al. (Annals of the rheumatic diseases, 2024)
Keywords: Adaptive immunity; Antibodies; Best practices; Cancer vaccines; Chronic obstructive pulmonary disease; Comorbidity; COVID-19 vaccines; Disease control; Disease-modifying Drugs (DMARDs); Enzyme-linked immunosorbent assay; Immune response (cell-mediated); Immune response (humoral); Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunomodulation; Interdisciplinary research; Lymphocytes T; Methotrexate; mRNA; Psoriatic arthritis; Rheumatoid arthritis; Rheumatology; Scientific Abstracts; Severe acute respiratory syndrome coronavirus 2; Vaccination/Immunization; γ-Interferon; Interdisciplinary research; Adaptive immunity; Disease-modifying Drugs (DMARDs); Vaccination/Immunization; Best practices